Literature DB >> 16860155

Definitions and diagnostic criteria for bronchopulmonary dysplasia.

Eduardo Bancalari1, Nelson Claure.   

Abstract

The changes in clinical presentation of bronchopulmonary dysplasia (BPD) in recent years have made many of the original definitions of BPD obsolete. The use of supplemental oxygen as a criterion for BPD diagnosis has many limitations. Supplemental oxygen is necessary to treat these infants, but at the same time it plays an important role in the pathogenesis of BPD. Because there are no accepted standards for supplemental oxygen administration, there are wide variations for its indications among different centers and this has a marked effect on the reported incidence of BPD. For this reason, it is essential to standardize the indications for supplemental oxygen when duration of oxygen therapy is used as the main criteria to diagnose BPD. Using supplemental oxygen need at specific time points does not necessarily reflect chronic lung damage and should be avoided as a single diagnostic criterion for BPD. A prolonged duration of supplemental oxygen is necessary to demonstrate the presence of chronic lung damage. The criteria based on supplemental oxygen at 36 weeks postmenstrual age has gained wide acceptance, but it is a less stringent criterion for the more mature infants. The longer the gestation, the shorter the time on oxygen that is required to meet this BPD criterion. None of the proposed criteria based on duration of oxygen therapy have shown a strong predictive value for long-term outcome. In view of all these shortcomings, it is essential to develop more objective physiologic tools to define the degree of lung damage and improve the prediction for long-term outcome in these infants.

Entities:  

Mesh:

Year:  2006        PMID: 16860155     DOI: 10.1053/j.semperi.2006.05.002

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  42 in total

Review 1.  Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Anne Pmc De Jaegere; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

Review 2.  Chronic lung disease in newborns.

Authors:  M Jeeva Sankar; Ramesh Agarwal; Ashok K Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2008-05-18       Impact factor: 1.967

3.  Small cerebellar hemorrhage in preterm infants: perinatal and postnatal factors and outcome.

Authors:  Sylke J Steggerda; Francisca T De Bruïne; Annette A van den Berg-Huysmans; Monique Rijken; Lara M Leijser; Frans J Walther; Gerda van Wezel-Meijler
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

4.  Surfactant protein B gene polymorphisms is associated with risk of bronchopulmonary dysplasia in Chinese Han population.

Authors:  Sheng Zhang; Xiaoying Zhang; Qiuping Li; Xiangyong Kong; Yupei Zhang; Xiujuan Wei; Jie Song; Zhichun Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.

Authors:  Jasmine Sahni; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

6.  Catch-up alveolarization in ex-preterm children: evidence from (3)He magnetic resonance.

Authors:  Manjith Narayanan; Caroline S Beardsmore; John Owers-Bradley; Cristian M Dogaru; Marius Mada; Iain Ball; Ruslan R Garipov; Claudia E Kuehni; Ben D Spycher; Michael Silverman
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

7.  Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia.

Authors:  Giovanni Vento; Chiara Tirone; Paola Lulli; Ettore Capoluongo; Franco Ameglio; Simona Lozzi; Francesco Cota; Fabio Mosca; Costantino Romagnoli; Irene Messana; Massimo Castagnola; Rosanna Inzitari
Journal:  Intensive Care Med       Date:  2009-09-25       Impact factor: 17.440

Review 8.  Can we improve outcome of congenital diaphragmatic hernia?

Authors:  L van den Hout; I Sluiter; S Gischler; A De Klein; R Rottier; H Ijsselstijn; I Reiss; D Tibboel
Journal:  Pediatr Surg Int       Date:  2009-09       Impact factor: 1.827

9.  Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Hyo Soon An; Eun Jung Bae; Gi Beom Kim; Bo Sang Kwon; Jae Suk Beak; Ee Kyung Kim; Han Suk Kim; Jung-Hwan Choi; Chung Il Noh; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

10.  Hybrid management of a large atrial septal defect and a patent ductus arteriosus in an infant with chronic lung disease.

Authors:  Simone F Pedra; Marcelo Jatene; Carlos Ac Pedra
Journal:  Ann Pediatr Cardiol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.